14.03.2019 • NewsBPElaine BurridgeJohnson Matthey

BP, Virent and Johnson Matthey in Bio-PX Pact

BP, Virent and Johnson Matthey in Bio-PX Pact (c) BP
BP, Virent and Johnson Matthey in Bio-PX Pact (c) BP

BP, Virent and Johnson Matthey have agreed to collaborate to further progress the commercialization of Virent’s Bioforming process for producing bio-paraxylene (PX), a key raw material for renewable polyester.

Under the terms of the agreement, BP will provide technical resources and also have exclusive rights to negotiate becoming the sole manufacturer of bio-PX using Virent’s technology.

“We consider Virent’s technology to be the leading route to commercial quantities of renewable bio-PX that may enable BP’s existing petrochemicals plants to produce a distinctive product in support of our commitment to advance a low carbon future,” said Charles Damianides, BP’s vice-president of petrochemicals technology and licensing.

The Bioforming route is based on a novel combination of aqueous phase reforming (APR) technology with modified conventional catalytic processing. The technology converts plant-based sugars into a range of drop-in hydrocarbon products that are identical to their petroleum-based counterparts. Virent said it can work with conventional sugars such as those obtained from existing sources (for example, corn wet mills and sugarcane mills), as well as a wide variety of cellulosic biomass from non-food sources.

In July 2016, Virent formed a consortium with Johnson Matthey, Toray, Coca-Cola and Andeavor (then Tesoro) to scale up and commercialize the Bioforming process. Andeavor, a subsidiary of Marathon Petroleum, then acquired Virent in September 2016.

Other companies working on bio-PX processes include Gevo and Anellotech. Last October, Anellotech announced it had started planning the design and engineering for a commercial-scale plant based on its Bio-TCat process, which produces fuels and chemicals from non-food biomass.

Gevo started up a demonstration plant for bio-PX in Silsbee, Texas, USA, in September 2013, supplying test quantities to Toray Industries for use in fibers and films.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.